Experts Raise Questions About Vioxx Decision
105508
Two leading heart experts called for urgent investigations on Wednesday into whether all painkilling drugs known as COX-2 inhibitors may raise the risk of heart attack in some people.
384984
Soon after the anti-arthritis and painkiller drug Vioxx was approved by the Food and Drug Administration in 1999, credible questions surfaced about the risk of serious cardiovascular problems in people who took it.
695199
Less than three months after Merck withdrew its pain-killer Vioxx from the US after concerns about side-effects, questions over Pfizer&#39;s competitor products are provoking
387871
Oct. 6, 2004 - Scientists in the United States and regulatory agencies in Europe on Wednesdsay questioned whether Celebrex and other pain relievers might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.
455531
A panel of experts reaches mixed conclusions on the safety and effectiveness of drug-coated stents.
202073
Americans should feel reasonably safe taking government-approved prescription drugs &#151; with a few caveats &#151; even after a popular arthritis medication was pulled from the market, medical experts say. But the problems with Vioxx raise questions about the Food and Drug Administration's safety review process and the length of time it took Merck to pull the drug, observers say.
608096
It might not just be Vioxx that carries a risk of heart problems. Scientists and European regulators say users of similar pain-relief medications also may have cause for concern.
544386
Scientists and European regulators are now questioning the safety of other pain relievers like Vioxx, saying these medications also might raise the risk of heart attack and stroke.
88844
Across the United States, doctors are struggling to decide which pain relievers to prescribe now that they know that popular drugs like Vioxx and Celebrex pose potentially serious heart risks.
49935
Description: A voluntary withdrawal of Vioxx from the market is the latest in a string of safety issues for the drug market. Dr. Alistair Wood, of the Vanderbilt School of Medicine, says the serious dangers
143642
On Sunday, 60 Minutes will run a story asking if Merck (nyse: MRK - news - people ) knew about the dangers of Vioxx, the arthritis drug that was pulled from the market because it doubled the risk of heart attack and stroke.
134259
&quot;We were wrong about Vioxx, but you can trust us on all those other meds,&quot; the FDA seems to be saying. If you enjoy this article, you may also be interested in an article entitled &#39;The FDA remains in state of denial about drug safety questions.
328328
An Oregon man stopped taking the painkiller Vioxx when it was pulled from the market, switching to Bextra. Then questions were raised about Bextra &#151; and four other drugs &#151; and he returned to his doctor with a new set of worries. Similar conversations are happening between doctors and patients all around the country.
128777
A top Republican lawmaker called Wednesday for Merck &amp; Company to answer questions about its withdrawn drug Vioxx on Nov. 18 at the first Congressional hearing to address the drug&#39;s safety problems.
161932
The problems with Vioxx, taken off the market last week, raise questions about the Food and Drug Administration's safety review process. Observers say longer clinical trials should be required.
592608
Lawyers for customers suing Merck &amp; Co. want to question CEO Raymond Gilmartin about what he knew about the dangers of Vioxx before the company withdrew the drug from the market because of health hazards.
19213
Less than six weeks after Vioxx was pulled from pharmacy shelves because of evidence it increased a patient&#39;s risk of heart attack or stroke, some researchers are raising